Domestic medical equipment is facing many development opportunities
In August, the National Health and Family Planning Commission and the Ministry of Industry and Information Technology jointly held a conference to promote the development and application of domestic medical equipment . Li Bin, director of the National Health Planning Commission, said that it will focus on promoting the use of domestic medical equipment in the top three hospitals. The Minister of Industry and Information Technology, Miao Wei, said that it will establish active use of domestic medical equipment. Incentives. In September, the Anti-Monopoly Bureau of the Ministry of Commerce conducted a survey on the centralized anti-monopoly review of medical devices in Shanghai.
The research and development and production technology of domestic medical devices are also improving. Guoxin Securities Financial Holdings Co., Ltd. research report pointed out that some medical device companies in China now have superb technology, such as medical imaging, and the quality and reliability of their products are not significantly different from those of multinational companies.
The National Health and Family Planning Commission announced on October 9 that it will gradually establish a graded diagnosis and treatment system that suits the current national conditions, and divert the general outpatient, rehabilitation and care undertaken by large and medium-sized hospitals to primary health care institutions. With the pilot and implementation of the grading diagnosis and treatment system, the pattern of “health entering the family, minor diseases at the grassroots level, serious illness to the hospital, and rehabilitation back to the grassroots level†will gradually take shape.
At present, primary hospitals are beginning to demand a large number of low-end magnetic resonance imaging equipment, and home medical equipment will become more popular. Family Health Consultant Industry analysts pointed out that the home medical device market is expected to grow by 25%. Domestic medical equipment is facing many development opportunities, and its market share is gradually expanding. However, to really reduce the cost of hospital inspections, to ease the problem of expensive medical treatment and difficult medical treatment, it depends on legislation and supervision.
Zhu Hengpeng, director of the Institute of Economic Research of the Chinese Academy of Social Sciences, and other people in the industry believe that the current rate of increase in the rate of medical device circulation in China is missing. If the government wants to rectify the medical device market and eliminate monopoly, it must first clarify the unreasonable interests of the parties in the market and specification.
Kehua Bio (002022): The company is the first diagnostic products company listed on the Shenzhen Stock Exchange. It integrates product research and development, production and sales, and has a complete industrial chain in the field of medical diagnosis. The company's main business covers three major areas such as in vitro diagnostic reagents, medical testing equipment, and vacuum blood collection systems.
Hejia shares (300273): The company specializes in the research and development, production, sales and service of medical equipment. Up to now, the company has formed four major business segments of tumor minimally invasive treatment equipment , medical molecular sieve oxygen equipment and engineering, routine diagnosis and treatment equipment and medical equipment distribution, and relies on the technical advantages and richness in the field of minimally invasive treatment and medical oxygen generation. The product reserve has become a comprehensive solution provider in the above-mentioned fields. The company pioneered the launch of “Hejia Tumor Minimally Invasive Comprehensive Treatment Solution†and series of treatment equipment with independent intellectual property rights, representing the more mature and advanced tumor treatment level in China, and promoting the treatment of cancer into “comprehensive and minimally invasive treatmentâ€. , targeting, personalization, a new era.
Yangpu Medical (300030): Yangpu Medical is a leading enterprise in the domestic vacuum blood collection system industry, providing technology, products and services based on professional solutions for clinical laboratory and clinical care. The main product is the third-generation vacuum blood collection system. It has good brand influence in the domestic high-end market, and it is the main supplier of vacuum blood collection system in hospitals above the third grade. The company is a leader in the analysis of pre-analysis control technology for specimens in clinical laboratory laboratories in China. It is a development strategy for the development of “specimen expertsâ€, “care experts†and “inspection experts†in the field of clinical laboratory and clinical nursing, focusing on clinical Inspection laboratories and clinical care provide the best solution for standardized operations.
Fire Extinguisher,Automatic Dcp Fire Extinguisher,Co2 Type Fire Extinguisher,Water Mist Extinguisher
NINGBO TOMAN IMP. & EXP. CO., LTD , https://www.tdotmfiresolution.com